McKenzie Kathryn B 4
4 · NEOGENOMICS INC · Filed Mar 5, 2019
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Award
Common Stock
2019-03-01+2,273→ 2,273 total - Award
Stock Option (Right to Buy)
2019-03-01$19.60/sh+13,894$272,322→ 13,894 totalExercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (13,894 underlying)
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $9.07From: 2018-10-18Exp: 2022-10-18→ Common Stock (25,000 underlying) - 48,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,000 underlying)
Footnotes (3)
- [F1]On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
- [F2]On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.